Multicentre, Open Label Study to Assess the Tolerability of P-3058 Nail Solution in Paediatric Patients Affected by Mild-to-moderate Onychomycosis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Polichem
- 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Sep 2017.
- 29 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.
- 29 Mar 2017 Status changed from recruiting to active, no longer recruiting.